AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
The Pharma Data
FEBRUARY 4, 2021
– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. – Full-Year Global Net Revenues from the Neuroscience Portfolio Were $3.496 Billion; Global Botox Therapeutic Net Revenues Were $1.387 Billion; Global Vraylar Net Revenues Were $951 Million.
52 
Let's personalize your content